Ader, Marilyn

Why Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome

Bergman, R. N., Kim, S. P., Catalano, K. J., Hsu, I. R., Chiu, J. D., Kabir, M., Hucking, K., & Ader, M. (2006) · Obesity

Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

Cited by 371

Insulin transport across capillaries is rate limiting for insulin action in dogs.

Yang, Y. J., Hope, I. D., Ader, M., & Bergman, R. N. (1989) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes Management and Research

Cited by 303

Role of Glucose Effectiveness in the Determination of Glucose Tolerance

Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C., & Bergman, R. N. (1996) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 290

Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects

Lee, A., Ader, M., Bray, G. A., & Bergman, R. N. (1992) · Diabetes

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 193

Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct Measurements

Ader, M., Pacini, G., Yang, Y. J., & Bergman, R. N. (1985) · Diabetes

Pancreatic function and diabetesDiabetes Management and Research

Cited by 169

Dose-Response Relationship Between Lymph Insulin and Glucose Uptake Reveals Enhanced Insulin Sensitivity of Peripheral Tissues

Ader, M., Poulin, R. A., Yang, Y. J., & Bergman, R. N. (1992) · Diabetes

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 20